taladegib (ENV 101) - Endeavor BioMed
Study: ENV-101 improves IPF lung function, reverses fibrosis (Pulmonary Fibrosis News) - Jun 7, 2024 - "'There is a tremendous need for IPF treatments that do more than slow the inevitable decline of lung function,' Toby M Maher, MD, PhD...said in a company press release. 'These preliminary signs of clinical and antifibrotic activity suggest that ENV-101 has the potential to change the trajectory of this otherwise relentless disease.'" 
Video • Idiopathic Pulmonary Fibrosis
https://pulmonaryfibrosisnews.com/news/lung-function-gains-scarring-descreases-seen-study-ipf-therapy-env-101/
 
Jun 7, 2024
 
Prev Next